Press Releases
CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland
CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide...
Articles
Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis
Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases such as Amyotrophic Lateral Sclerosis (ALS) and spinal muscular atrophy, have a profound impact on...
News
Innovative Stem Cell Therapies: Transforming Regenerative Medicine and Patient Care
In recent years, stem cell therapy has emerged as a groundbreaking approach in regenerative medicine, offering patients innovative ways to support healing and recovery....
News
Managing Construction Waste in the Pharmaceutical Industry: Best Practices
The pharmaceutical industry, with its strict regulatory requirements and high standards, often faces unique challenges when managing waste, particularly during construction projects. Whether building...
Press Releases
Andelyn Biosciences Expands AAV Curator Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and...
COLUMBUS, OH -Â Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expanded its AAV Curatorâ„¢...
Press Releases
Massilly Group to acquire the assets of Hoffmann Neopac’s Tin Business
Hoffmann Neopac has signed a sale and purchase agreement to sell the assets of its tin business to the Massilly Group that should be...
Press Releases
Everest Group Recognizes Indegene as a Front-Runner in GenAI Life Sciences Market Adoption
Bengaluru, India: Everest Group, a leading global research and consulting firm, has recognized Indegene as a front-runner in generative AI (GenAI) life sciences market...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
